Dr. Cimbala is a director in the Biotechnology/Chemical Group. Her practice is focused on biotechnology patent procurement and evaluation, including the preparation of patent applications, their prosecution and appeal, and related opinion matters.
Her technical expertise is in the area of biotechnology, and especially molecular biology, enzymology, and molecular endocrinology. Dr. Cimbala also has experience in clean technology industrial enzyme applications for the pulp and paper industry and in textile processing.
Dr. Cimbala completed her postdoctoral research with Dr. Richard Hansen at Case Western Reserve University. Before changing her career into patent law, she was an Assistant Professor in Biochemistry at the University of Massachusetts Medical Center in Worcester, Massachusetts. While at Worcester, her research was funded by grants from the NIH, the American Diabetes Association, and the March of Dimes, and concerned the molecular mechanism of peptide hormone action. She was a member of the NIH Biomedical Sciences-2 Study Section.
Articles in the National Law Review database by Michele A. Cimbala, Ph.D.